new glp 1 drugs in development What to Make of the GLP-1 Coverage and Cost Landscape Upcoming wave of hormone-based therapies

But Drs

While early concerns regarding pancreatic and thyroid cancer have been largely attenuated by recent evidence, issues such as gallbladder and biliary disorders, psychiatric safety, and perioperative aspiration risk require ongoing investigation

Ozempic and other GLP-1 receptor agonists dampen mesolimbic dopamine signaling, reducing reward salience and drug reinforcement across addictions

That means employers are absorbing significant pharmacy costs without consistently seeing the health outcomes that would justify the investment through reduced downstream medical spending

GIP can enhance insulin secretion in the postprandial state and increase the anabolic effect of insulin in adipose tissue, thus promoting adipogenesis and preadipocyte differentiation [31, 32], while GLP-1RA can control blood glucose and lower body weight, reduce postprandial lipoprotein secretion, decrease systemic tissue inflammation, and help improve hepatic lipid metabolism disorders [3335], which has some beneficial effects on NAFLD

WEDNESDAY, April 2, 2025 (HealthDay News) -- The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform